4.8 Article

Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity

Journal

NATURE MEDICINE
Volume 12, Issue 10, Pages 1208-1212

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm1413

Keywords

-

Funding

  1. NCRR NIH HHS [RR000163, P51 RR000163] Funding Source: Medline
  2. NIAID NIH HHS [AI054458, R01 AI054458] Funding Source: Medline

Ask authors/readers for more resources

Identification of pathogen-specific T cells has been greatly facilitated by the advent of synthetic peptide-major histocompatibility complex (MHC) tetramers. In many cases, however, specific epitopes have not been defined, necessitating detection methods that function independently of exact peptide-MHC specificity. Lymphocytes acquire surface proteins from antigen-presenting cells (APCs), and we have exploited this phenomenon to develop the T-cell recognition of APCs by protein transfer (TRAP) assay. This method is based on biotinylation and streptavidin-fluorochrome labeling of APCs, followed by subsequent acquisition of this label by antigen-specific T cells. The TRAP procedure detects MHC class l-restricted T cells regardless of their cytokine profiles or peptide-MHC affinities, and provides a versatile tool for monitoring the phenomenon of APC membrane acquisition by antigen-specific T cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available